RATES OF PERIPROSTHETIC JOINT INFECTION FOLLOWING ASEPTIC REVISION TOTAL HIP ARTHROPLASTY ARE NOT REDUCED WITH EXTENDED ORAL ANTIBIOTIC PROPHYLAXIS

INTRODUCTION & AIMS Use of extended oral antibiotic prophylaxis (EOAP) following total hip arthroplasty (THA) has increased despite mixed evidence and no national guidelines. Since revision THA (rTHA) carries increased periprosthetic joint infection (PJI) risk, EOAP use in this setting is particularly relevant. We evaluated postoperative infectious outcomes following rTHA with and without EOAP. METHODS Patients undergoing initial aseptic rTHA were identified in the 2010-2023 Q1 PearlDiver database. Those who received EOAP, defined as postoperative oral antibiotic use >1 day and <2 weeks, were identified. To avoid antibiotic prescriptions for other indications, patients with non-hip infections during the first postoperative week were excluded. EOAP patients were matched 1:4 to controls based on age, sex, and Elixhauser Comorbidity Index (ECI). Median follow-up was 3.74 years in the EOA cohort, and 5.66 years in the no-EOA cohort. Other comorbidities controlled for as covariates included: smoking, BMI≥35kg/m2, chronic kidney disease, autoimmune conditions, and diabetes. The primary endpoint was PJI, with time-to-event analysis performed using Cox regression. Outcomes were assessed at sequential intervals through five-years. Rates of other postoperative infections, emergency department visits and hospital readmissions occurring between 7-90 days were evaluated using multivariable regression. Significance defined as P<0.05. RESULTS After matching, 2,195 EOAP patients were compared to 8,745 control patients. EOAP was not associated with reduced hazard of PJI following 90 days (Hazard ratio [HR]=0.95), 6 months (HR=1.01), 1 year (HR=0.98), 2 years (HR=1.02), or 5 years (HR=0.97) postoperatively (all p>0.05). EOAP patients had lower adjusted odds of experiencing a urinary tract infection (UTI, odds ratio [OR]=0.70, p=0.015) and readmission (OR=0.74, p<0.001) between 7-90 days, without increased odds of C. difficile colitis. CONCLUSION EOAP following aseptic rTHA was not associated with reduced risk of PJI over 5 years. Nonetheless, its use correlated with lower odds of UTI and readmission, suggesting possible alternate short-term benefits

Authors

Institutions

Publication Details

Journal
Orthopaedic Proceedings
Published
2026-11-06
DOI
https://doi.org/10.1302/1358-992x.2026.11.058
Primary Topic
Orthopedic Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

RATES OF PERIPROSTHETIC JOINT INFECTION FOLLOWING ASEPTIC REVISION TOTAL HIP ARTHROPLASTY ARE NOT REDUCED WITH EXTENDED ORAL ANTIBIOTIC PROPHYLAXIS

Joshua G. Sanchez, Julian Smith-Voudouris, Ilda B. Molloy, J. David Grauer et al.
5 links
Orthopaedic Proceedings
Orthopedic Infections and Treatments
article

RATES OF PERIPROSTHETIC JOINT INFECTION FOLLOWING ASEPTIC REVISION TOTAL HIP ARTHROPLASTY ARE NOT REDUCED WITH EXTENDED ORAL ANTIBIOTIC PROPHYLAXIS

Joshua G. Sanchez, Julian Smith-Voudouris, Ilda B. Molloy, J. David Grauer, Katie M. Zehner
article en

Abstract

INTRODUCTION & AIMS Use of extended oral antibiotic prophylaxis (EOAP) following total hip arthroplasty (THA) has increased despite mixed evidence and no national guidelines. Since revision THA (rTHA) carries increased periprosthetic joint infection (PJI) risk, EOAP use in this setting is particularly relevant. We evaluated postoperative infectious outcomes following rTHA with and without EOAP. METHODS Patients undergoing initial aseptic rTHA were identified in the 2010-2023 Q1 PearlDiver database. Those who received EOAP, defined as postoperative oral antibiotic use >1 day and <2 weeks, were identified. To avoid antibiotic prescriptions for other indications, patients with non-hip infections during the first postoperative week were excluded. EOAP patients were matched 1:4 to controls based on age, sex, and Elixhauser Comorbidity Index (ECI). Median follow-up was 3.74 years in the EOA cohort, and 5.66 years in the no-EOA cohort. Other comorbidities controlled for as covariates included: smoking, BMI≥35kg/m2, chronic kidney disease, autoimmune conditions, and diabetes. The primary endpoint was PJI, with time-to-event analysis performed using Cox regression. Outcomes were assessed at sequential intervals through five-years. Rates of other postoperative infections, emergency department visits and hospital readmissions occurring between 7-90 days were evaluated using multivariable regression. Significance defined as P<0.05. RESULTS After matching, 2,195 EOAP patients were compared to 8,745 control patients. EOAP was not associated with reduced hazard of PJI following 90 days (Hazard ratio [HR]=0.95), 6 months (HR=1.01), 1 year (HR=0.98), 2 years (HR=1.02), or 5 years (HR=0.97) postoperatively (all p>0.05). EOAP patients had lower adjusted odds of experiencing a urinary tract infection (UTI, odds ratio [OR]=0.70, p=0.015) and readmission (OR=0.74, p<0.001) between 7-90 days, without increased odds of C. difficile colitis. CONCLUSION EOAP following aseptic rTHA was not associated with reduced risk of PJI over 5 years. Nonetheless, its use correlated with lower odds of UTI and readmission, suggesting possible alternate short-term benefits

Orthopaedic ProceedingsVol. 108-B(SUPP_11)
Yale University (US)
Good health and well-being
Openalex Percentile: Top 12%
Orthopedic Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon